Drawing for MYOLUTION

USPTO serial 79181734

MYOLUTION

Reviewed by CopyMark Law Group

Reg. 5121570Status 709
Filing date
Status date
Registration date
Jan 17, 2017
Examiner
LEASER, ANDREW C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MYOLUTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treating orthopedic, cardiovascular, central nervous system, pain, oncology, and nerve growth conditions; Pharmaceutical preparations for the treatment of infectious diseases; veterinary preparations for treating orthopedic, cardiovascular, central nervous system, pain, oncology, and nerve growth conditions; Veterinary preparations for the treatment of infectious diseases; veterinary vaccines; medical preparations for the treatment of wound closure; medical preparations for cleansing the skin for medical use; medical preparations for bone fractures; Pharmaceutical and sanitary preparations all for medical purposes, namely, medicated skin cleansing, skin protection and skin care, medicated foot care preparations; antiseptics; medicated ointments for treating dermatological conditions; chemical preparations for sanitary purposes; chemical preparations for medical purposes, namely, for treating skin diseases and for combating skin parasites; pharmaceutical preparations for treating skin diseases and for combating skin parasites; medicated burn ointments; chemical preparations for medical, pharmaceutical and veterinary purposes, namely, drug delivery agents in the form of a coating for tablets, powders and capsules that facilitate the delivery of a wide range of pharmaceuticals; amino acids for medical and veterinary purposes; esters, greases and oils for medical and veterinary purposes; salts, in particular sodium and potassium for medical purposes; steroids; biological preparations for medical and veterinary purposes, namely, antibacterial pharmaceuticals and antidiabetic pharmaceuticals; medicated bath preparations; therapeutic medicated bath preparations; tissues impregnated with pharmaceutical or disinfectant preparations, in particular for skin care and skin cleansing and for use as disinfectants for hygienic and sanitary purposes; ferments for pharmaceutical purposes; dietetic yeast or starch for medical use; yeast or starch for pharmaceutical purposes; enzymes and enzyme preparations for medical and veterinary purposes; bacteriological preparations for medical and veterinary purposes; sanitary preparations for medical purposes; sanitary preparations and articles, namely, sanitary towels, sanitary napkins; sanitary preparations and articles, namely, pharmaceutical astringents, bandages for dressings, bandages for skin wounds and surgical dressings; dietetic food, substances, and preparations adapted for medical or veterinary use, namely, pasta, crackers, bread, and sugar; dietary supplements; albuminous preparations for medical purposes, namely, protein supplements; medicated confectionery; medicinal drinks; dietetic beverages adapted for medical purposes; medical preparations for slimming purposes; food for babies; nutritional supplements for humans; dietary supplements for animals; nutritional supplements; sugar, in particular candy and glucose for medical purposes; glucose for medical purposes; albuminous foodstuffs for medical purposes, namely, protein nutritional supplements; protein dietary supplements; dietary fibre as a nutritional supplement; mineral food supplements; mineral supplements, namely, preparations of trace elements for human and animal use; vitamin preparations; medical plasters; materials for dressings, namely, gauze and wadding; material for stopping teeth; dental impression materials; dental preparations and articles, namely, adhesives for dental use, dental alloys, dental composite materials, and medicines for dental purposes; disinfectants; preparations for destroying vermin; fungicides, herbicides; food supplements; enzyme food supplements; dietary food supplements; mineral food supplements; health food supplements; food supplements, namely, anti-oxidants; amino acids for nutritional purposes; Dietary and nutritional supplements for endurance sports; Medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; powered nutritional supplement drink mix and concentrate; nutritional supplement shakes; nutritional supplement energy bars; nutritionally fortified beverages for medical purpose; nutritional supplements, namely, probiotic compositionsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 13, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
May 6, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 11, 2024INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 11, 2024INPCINVALIDATION PROCESSED—
Mar 28, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 28, 2023C71TCANCELLED SECTION 71—
Jan 17, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 12, 2020CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 5, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 18, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 18, 2017FIMPFINAL DISPOSITION PROCESSED—
Apr 17, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 17, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 11, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 1, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 1, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 12, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 12, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 26, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 17, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 15, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 13, 2016ALIEASSIGNED TO LIE—
Sep 6, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2016RFNPREFUSAL PROCESSED BY IB—
Mar 8, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 8, 2016RFRRREFUSAL PROCESSED BY MPU—
Mar 5, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 4, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2016DOCKASSIGNED TO EXAMINER—
Feb 13, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 9, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 4, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance